Cyclodextrin derivative developed by Cyclarity in clinical trial

Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX, … Continue reading Cyclodextrin derivative developed by Cyclarity in clinical trial